Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets

https://m2.mtmt.hu/ eng 2026-05-02 14:57 JournalArticle 36144886 VALIDATED true 0 false 2026-04-21T06:31:28.699+0000 2025-12-27T07:28:54.190+0000 2025-05-16T09:24:34.015+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Rita Tichy (SE_KK_Admin5_TR, admin) true 10026589 2026-03-27T10:21:24.557+0000 2026-03-27T10:21:24.557+0000 2025-05-26T09:27:30.758+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Delalat, Simin Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets true true /api/journal/10011378 REVIEWED CARDIOVASCULAR DIABETOLOGY 1475-2840 1475-2840 true false 10011378 false 10011378 true 1475-2840 1475-2840 Journal FOREIGN 24 1 211 211 19 2025 Funding 2053307 /api/funding/2053307 (RRF-2.3.1-21-2022-00003) false true Funding 2053308 /api/funding/2053308 National Research, Development and Innovation Office (NKFIH) of Hungary(FK134751) false true Funding 2053309 /api/funding/2053309 (TKP2021-EGA-23) Funder: Ministry for Innovation and Technology false true true 2025 true true true false true false GOLD 2026-04-21 true https://doi.org/10.1186/s12933-025-02734-4 25 0 25 23 1 25 25 25 15 25 25 23 23 23 2 0 25 23 25 23 0 7 7 Folyóiratcikk Journal Article 24 25 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 10 9 10 9 2026 0 15 14 15 14 D1 false 10040905 false false false 2025-05-15T09:26:39.634+0000 Biofizikai és Sugárbiológiai Intézet (SE / AOK / I); Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE); HCEMM-SE In Vivo Képalkotó Műszerközpont (SE / AOK / I / BSI); HCEMM-SE Kardiometabolikus Immunológia Kutatócs... (SE / AOK / I / FFI); Klinikai Fiziológiai Tanszék (DE / ÁOK / KardI) 6 31 6 27 0 true Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 126553201 /api/authorship/126553201 Delalat, Simin 1 0.037037037 true false false Delalat Simin true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553202 /api/authorship/126553202 Sultana, Innas* 2 0.037 true false false Sultana Innas true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553203 /api/authorship/126553203 Osman, Hersh* 3 0.037 true false false Osman Hersh true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553204 /api/authorship/126553204 Sieme, Marcel* 4 0.037 true false false Sieme Marcel true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553205 /api/authorship/126553205 Zhazykbayeva, Saltanat 5 0.037037037 false false false Zhazykbayeva Saltanat true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553206 /api/authorship/126553206 Herwig, Melissa 6 0.037037037 false false false Herwig Melissa true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553207 /api/authorship/126553207 Budde, Heidi 7 0.037037037 false false false Budde Heidi true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553208 /api/authorship/126553208 Kovács, Árpád [Kovács, Árpád (Kardiológia), author] Klinikai Fiziológiai Tanszék (UD / KardI) 8 0.037037037 false false false Author 10055258 /api/author/10055258 Árpád Kovács (Kardiológia) Kovács Árpád true 10055258 true Kovács Árpád true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553209 /api/authorship/126553209 Kaçmaz, Mustafa 9 0.037037037 false false false Kaçmaz Mustafa true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553210 /api/authorship/126553210 Göztepe, Eda 10 0.037037037 false false false Göztepe Eda true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553211 /api/authorship/126553211 Borgmann, Natalie 11 0.037037037 false false false Borgmann Natalie true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553212 /api/authorship/126553212 Shahriari, Gelareh 12 0.037037037 false false false Shahriari Gelareh true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553213 /api/authorship/126553213 Sasko, Benjamin 13 0.037037037 false false false Sasko Benjamin true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553214 /api/authorship/126553214 Wintrich, Jan 14 0.037037037 false false false Wintrich Jan true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553215 /api/authorship/126553215 Haldenwang, Peter 15 0.037037037 false false false Haldenwang Peter true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553216 /api/authorship/126553216 Schmidt, Wolfgang E. 16 0.037037037 false false false Schmidt Wolfgang E. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553217 /api/authorship/126553217 Fenske, Wiebke 17 0.037037037 false false false Fenske Wiebke true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553218 /api/authorship/126553218 Khan, Muchtiar 18 0.037037037 false false false Khan Muchtiar true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553219 /api/authorship/126553219 Jaquet, Kornelia 19 0.037037037 false false false Jaquet Kornelia true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553220 /api/authorship/126553220 Mügge, Andreas 20 0.037037037 false false false Mügge Andreas true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553221 /api/authorship/126553221 Máthé, Domokos [Máthé, Domokos (Molekuláris képal...), author] Departmnet of Biophysics and Radiation Biology (SU / FM / I); ACF-SU In Vivo Imaging (SU / FM / I / DBRB) 21 0.037 false false false Author 10054788 /api/author/10054788 Domokos Máthé (Molekuláris képalkotás) Máthé Domokos true 10054788 true Máthé Domokos true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553222 /api/authorship/126553222 Tóth, Viktória E. [Tóth, Viktória (Farmakológia), author] HCEMM-SU Cardiometabolic Immunology Research Group (SU / FM / I / DPP); Centre for Pharmacology and Pharmaceutical Rese... (SU / KSZE); Department of Pharmacology and Pharmacotherapy (SU / FM / I) 22 0.037 false false false Author 10040905 /api/author/10040905 Viktória Tóth (Farmakológia) Tóth Viktória true 10040905 true Tóth Viktória E. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553223 /api/authorship/126553223 Varga, Zoltán V. [Varga, Zoltán (kardiovaszkuláris...), author] HCEMM-SU Cardiometabolic Immunology Research Group (SU / FM / I / DPP); Centre for Pharmacology and Pharmaceutical Rese... (SU / KSZE); Department of Pharmacology and Pharmacotherapy (SU / FM / I) 23 0.037 false false false Author 10028393 /api/author/10028393 Zoltán Varga (kardiovaszkuláris kutatás) Varga Zoltán true 10028393 true Varga Zoltán V. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553224 /api/authorship/126553224 Ferdinandy, Péter [Ferdinandy, Péter (Farmakológia, mol...), author] HCEMM-SU Cardiometabolic Immunology Research Group (SU / FM / I / DPP); Centre for Pharmacology and Pharmaceutical Rese... (SU / KSZE); Department of Pharmacology and Pharmacotherapy (SU / FM / I) 24 0.037 false false false Author 10010125 /api/author/10010125 Péter Ferdinandy (Farmakológia, molekuláris medicina) Ferdinandy Péter true 10010125 true Ferdinandy Péter true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553225 /api/authorship/126553225 El-Battrawy, Ibrahim 25 0.037037037 false false false El-Battrawy Ibrahim true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553226 /api/authorship/126553226 van Heerebeek, Loek** 26 0.037 false true false van Heerebeek Loek true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126553227 /api/authorship/126553227 Hamdani, Nazha ✉ [Hamdani, Nazha (Medicine), author] 27 0.037 false true true Author 10086357 /api/author/10086357 Nazha Hamdani (Medicine) Hamdani Nazha true true Hamdani Nazha true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 29376821 /api/publicationidentifier/29376821 DOI: 10.1186/s12933-025-02734-4 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1186/s12933-025-02734-4 https://doi.org/10.1186/s12933-025-02734-4 false true PublicationIdentifier 29413629 /api/publicationidentifier/29413629 WoS: 001488651800006 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001488651800006 https://www.webofscience.com/wos/woscc/full-record/001488651800006 true true PublicationIdentifier 29413640 /api/publicationidentifier/29413640 Scopus: 105005094697 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105005094697 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105005094697 true true PublicationIdentifier 29376822 /api/publicationidentifier/29376822 PubMed: 40369521 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 40369521 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40369521&dopt=Abstract false true Classification 12197 /api/classification/12197 Pharmacology, pharmacogenomics, drug discovery and design, drug therapy true true SjrRating 11563269 /api/sjrrating/11563269 sjr:D1 (2025) Scopus - Cardiology and Cardiovascular Medicine CARDIOVASCULAR DIABETOLOGY 1475-2840 1475-2840 15 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2705 /api/classificationexternal/2705 Scopus - Cardiology and Cardiovascular Medicine true 2705 true D1 FROM_LAST_YEAR true true Reference 65850968 /api/reference/65850968 1. Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010;88(10):993–1001. https://doi.org/10.1007/s00109-010-0663-9., DOI: 10.1007/s00109-010-0663-9 1 10.1007/s00109-010-0663-9 false true Reference 65850969 /api/reference/65850969 2. Sasso FC, et al. Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes. J Diabetes Res. 2018;2018:1–8. https://doi.org/10.1155/2018/3106056., DOI: 10.1155/2018/3106056 2 10.1155/2018/3106056 false true Reference 65850970 /api/reference/65850970 3. IDF Diabetes Atlas, 9th edn. Federation ID, editor. Brussels: International Diabetes Federation (2019). 2019. 3 false true Reference 65850971 /api/reference/65850971 4. Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122(4):624–38. https://doi.org/10.1161/CIRCRESAHA.117.311586., DOI: 10.1161/CIRCRESAHA.117.311586 4 10.1161/CIRCRESAHA.117.311586 false true Reference 65850972 /api/reference/65850972 5. Jankauskas SS, et al. Heart failure in diabetes. Metabolism. 2021;125:154910. https://doi.org/10.1016/j.metabol.2021.154910., DOI: 10.1016/j.metabol.2021.154910 5 10.1016/j.metabol.2021.154910 false true Reference 65850973 /api/reference/65850973 6. Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745–807. https://doi.org/10.1152/physrev.00030.2020., DOI: 10.1152/physrev.00030.2020 6 10.1152/physrev.00030.2020 false true Reference 65850974 /api/reference/65850974 7. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34(1):29–34. https://doi.org/10.1016/0002-9149(74)90089-7., DOI: 10.1016/0002-9149(74)90089-7 7 10.1016/0002-9149(74)90089-7 false true Reference 65850975 /api/reference/65850975 8. Marinescu KK, Uriel N, Mann DL, Burkhoff D. Left ventricular assist device-induced reverse remodeling: it’s not just about myocardial recovery. Expert Rev Med Devices. 2017;14(1):15–26. https://doi.org/10.1080/17434440.2017.1262762., DOI: 10.1080/17434440.2017.1262762 8 10.1080/17434440.2017.1262762 false true Reference 65850976 /api/reference/65850976 9. Aronow WS. Current treatment of heart failure with reduction of left ventricular ejection fraction. Expert Rev Clin Pharmacol. 2016;9(12):1619–31. https://doi.org/10.1080/17512433.2016.1242067., DOI: 10.1080/17512433.2016.1242067 9 10.1080/17512433.2016.1242067 false true Reference 65850977 /api/reference/65850977 10. Alsamara M, Alharethi R. Heart failure with preserved ejection fraction. Expert Rev Cardiovasc Ther. 2014;12(6):743–50. https://doi.org/10.1586/14779072.2014.911086., DOI: 10.1586/14779072.2014.911086 10 10.1586/14779072.2014.911086 false true Reference 65850978 /api/reference/65850978 11. Rogers FJ, Gundala T, Ramos JE, Serajian A. Heart failure with preserved ejection fraction. J Am Osteopath Assoc. 2015;115(7):432–42. https://doi.org/10.7556/jaoa.2015.089., DOI: 10.7556/jaoa.2015.089 11 10.7556/jaoa.2015.089 false true Reference 65850979 /api/reference/65850979 12. Abudureyimu M, et al. Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics. J Mol Cell Biol. 2022;14(5):mjac028. https://doi.org/10.1093/jmcb/mjac028., DOI: 10.1093/jmcb/mjac028 12 10.1093/jmcb/mjac028 false true Reference 65850980 /api/reference/65850980 13. Wang ZV, Hill JA. Protein quality control and metabolism: bidirectional control in the heart. Cell Metab. 2015;21(2):215–26. https://doi.org/10.1016/j.cmet.2015.01.016., DOI: 10.1016/j.cmet.2015.01.016 13 10.1016/j.cmet.2015.01.016 false true Reference 65850981 /api/reference/65850981 14. Yang L, Zhao D, Ren J, Yang J. Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2015;1852(2):209–18. https://doi.org/10.1016/j.bbadis.2014.05.006., DOI: 10.1016/j.bbadis.2014.05.006 14 10.1016/j.bbadis.2014.05.006 false true Reference 65850982 /api/reference/65850982 15. Hassoun R, et al. Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy. Int J Cardiol. 2021;344:160–9. https://doi.org/10.1016/j.ijcard.2021.09.009., DOI: 10.1016/j.ijcard.2021.09.009 15 10.1016/j.ijcard.2021.09.009 false true Reference 65850983 /api/reference/65850983 16. Kaur N, Raja R, Ruiz-Velasco A, Liu W. Cellular protein quality control in diabetic cardiomyopathy: from bench to bedside. Front Cardiovasc Med. 2020;7:585309. https://doi.org/10.3389/fcvm.2020.585309., DOI: 10.3389/fcvm.2020.585309 16 10.3389/fcvm.2020.585309 false true Reference 65850984 /api/reference/65850984 17. Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62(6):670. https://doi.org/10.1007/s00018-004-4464-6., DOI: 10.1007/s00018-004-4464-6 17 10.1007/s00018-004-4464-6 false true Reference 65850985 /api/reference/65850985 18. Benjamin IJ, McMillan DR. Stress (Heat Shock) proteins. Circ Res. 1998;83(2):117–32. https://doi.org/10.1161/01.RES.83.2.117., DOI: 10.1161/01.RES.83.2.117 18 10.1161/01.RES.83.2.117 false true Reference 65850986 /api/reference/65850986 19. Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev. 2009;61(4):310–8. https://doi.org/10.1016/j.addr.2009.02.003., DOI: 10.1016/j.addr.2009.02.003 19 10.1016/j.addr.2009.02.003 false true Reference 65850987 /api/reference/65850987 20. Arrigo, A-P. The cellular ‘networking’ of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. In Molecular aspects of the stress response: chaperones, membranes and networks, New York: Springer New York; pp. 14–26. https://doi.org/10.1007/978-0-387-39975-1_2., DOI: 10.1007/978-0-387-39975-1_2 20 10.1007/978-0-387-39975-1_2 false true Reference 65850988 /api/reference/65850988 21. Wang RC, Levine B. Autophagy in cellular growth control. FEBS Lett. 2010;584(7):1417–26. https://doi.org/10.1016/j.febslet.2010.01.009., DOI: 10.1016/j.febslet.2010.01.009 21 10.1016/j.febslet.2010.01.009 false true Reference 65850989 /api/reference/65850989 22. Gurusamy N, Das D. Is autophagy a double-edged sword for the heart? Acta Physiol Hung. 2009;96(3):267–76. https://doi.org/10.1556/APhysiol.96.2009.3.2., DOI: 10.1556/APhysiol.96.2009.3.2 22 10.1556/APhysiol.96.2009.3.2 false true Reference 65850990 /api/reference/65850990 23. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900–17. https://doi.org/10.1016/j.cell.2010.02.034., DOI: 10.1016/j.cell.2010.02.034 23 10.1016/j.cell.2010.02.034 false true Reference 65850991 /api/reference/65850991 24. Chan YK, Sung HK, Jahng JWS, Kim GHE, Han M, Sweeney G. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells. Mol Cell Endocrinol. 2016;430:68–76. https://doi.org/10.1016/j.mce.2016.04.006., DOI: 10.1016/j.mce.2016.04.006 24 10.1016/j.mce.2016.04.006 false true Reference 65850992 /api/reference/65850992 25. Jung CH, Ro S-H, Cao J, Otto NM, Kim D-H. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287–95. https://doi.org/10.1016/j.febslet.2010.01.017., DOI: 10.1016/j.febslet.2010.01.017 25 10.1016/j.febslet.2010.01.017 false true Reference 65850993 /api/reference/65850993 26. Wang S, Li H, Yuan M, Fan H, Cai Z. Role of AMPK in autophagy. Front Physiol. 2022;13:1015500. https://doi.org/10.3389/fphys.2022.1015500., DOI: 10.3389/fphys.2022.1015500 26 10.3389/fphys.2022.1015500 false true Reference 65850994 /api/reference/65850994 27. Haye A, Ansari MA, Rahman SO, Shamsi Y, Ahmed D, Sharma M. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: a molecular landscape. Eur J Pharmacol. 2020;888:173376. https://doi.org/10.1016/j.ejphar.2020.173376., DOI: 10.1016/j.ejphar.2020.173376 27 10.1016/j.ejphar.2020.173376 false true Reference 65850995 /api/reference/65850995 28. Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114(3):549–64. https://doi.org/10.1161/CIRCRESAHA.114.302022., DOI: 10.1161/CIRCRESAHA.114.302022 28 10.1161/CIRCRESAHA.114.302022 false true Reference 65850996 /api/reference/65850996 29. Guo R, Zhang Y, Turdi S, Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2013;1832(8):1136–48. https://doi.org/10.1016/j.bbadis.2013.03.013., DOI: 10.1016/j.bbadis.2013.03.013 29 10.1016/j.bbadis.2013.03.013 false true Reference 65850997 /api/reference/65850997 30. Hu N, Zhang Y. TLR4 knockout attenuated high fat diet-induced cardiac dysfunction via NF-κB/JNK-dependent activation of autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2017;1863(8):2001–11. https://doi.org/10.1016/j.bbadis.2017.01.010., DOI: 10.1016/j.bbadis.2017.01.010 30 10.1016/j.bbadis.2017.01.010 false true Reference 65850998 /api/reference/65850998 31. Kandadi MR, Panzhinskiy E, Roe ND, Nair S, Hu D, Sun A. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: role of AMPK-dependent autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2015;1852(2):299–309. https://doi.org/10.1016/j.bbadis.2014.07.004., DOI: 10.1016/j.bbadis.2014.07.004 31 10.1016/j.bbadis.2014.07.004 false true Reference 65850999 /api/reference/65850999 32. Peh ZH, et al. Inflammation as a therapeutic target in heart failure with preserved ejection fraction. Front Cardiovasc Med. 2023;10:1125687. https://doi.org/10.3389/fcvm.2023.1125687., DOI: 10.3389/fcvm.2023.1125687 32 10.3389/fcvm.2023.1125687 false true Reference 65851000 /api/reference/65851000 33. Graham B, Gibson SB. The two faces of NF?B in cell survival responses. Cell Cycle. 2005;4(10):1342–5. https://doi.org/10.4161/cc.4.10.2047., DOI: 10.4161/cc.4.10.2047 33 10.4161/cc.4.10.2047 false true Reference 65851001 /api/reference/65851001 34. Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfield MM, Linke WA. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res. 2013;97(3):464–71. https://doi.org/10.1093/cvr/cvs353., DOI: 10.1093/cvr/cvs353 34 10.1093/cvr/cvs353 false true Reference 65851002 /api/reference/65851002 35. Hamdani N, et al. Crucial role for Ca2+/calmodulin-dependent protein kinase-II delta in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Biophys J. 2013;104(2):18a. https://doi.org/10.1016/j.bpj.2012.11.129., DOI: 10.1016/j.bpj.2012.11.129 35 10.1016/j.bpj.2012.11.129 false true Reference 65851003 /api/reference/65851003 36. Kolijn D, et al. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation. Cardiovasc Res. 2021;117(2):495–507. https://doi.org/10.1093/cvr/cvaa123., DOI: 10.1093/cvr/cvaa123 36 10.1093/cvr/cvaa123 false true Reference 65851004 /api/reference/65851004 37. Herwig M, et al. Protein kinase D plays a crucial role in maintaining cardiac homeostasis by regulating post-translational modifications of myofilament proteins. Int J Mol Sci. 2024;25(5):2790. https://doi.org/10.3390/ijms25052790., DOI: 10.3390/ijms25052790 37 10.3390/ijms25052790 false true Reference 65851005 /api/reference/65851005 38. Kolijn D, et al. Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator. Front Physiol. 2020;11:35. https://doi.org/10.3389/fphys.2020.00345., DOI: 10.3389/fphys.2020.00345 38 10.3389/fphys.2020.00345 false true Reference 65851006 /api/reference/65851006 39. Franssen C, et al. Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail. 2016;4(4):312–24. https://doi.org/10.1016/j.jchf.2015.10.007., DOI: 10.1016/j.jchf.2015.10.007 39 10.1016/j.jchf.2015.10.007 false true Reference 65851007 /api/reference/65851007 40. van Heerebeek L, et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126(7):830–9. https://doi.org/10.1161/CIRCULATIONAHA.111.076075., DOI: 10.1161/CIRCULATIONAHA.111.076075 40 10.1161/CIRCULATIONAHA.111.076075 false true Reference 65851008 /api/reference/65851008 41. Satheesan A, Kumar J, Leela KV, Murugesan R, Chaithanya V, Angelin M. Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology. 2024;32(5):2753–79. https://doi.org/10.1007/s10787-024-01556-2., DOI: 10.1007/s10787-024-01556-2 41 10.1007/s10787-024-01556-2 false true Reference 65851009 /api/reference/65851009 42. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. https://doi.org/10.1038/sigtrans.2017.23., DOI: 10.1038/sigtrans.2017.23 42 10.1038/sigtrans.2017.23 false true Reference 65851010 /api/reference/65851010 43. Kasner M, et al. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol. 2011;57(8):977–85. https://doi.org/10.1016/j.jacc.2010.10.024., DOI: 10.1016/j.jacc.2010.10.024 43 10.1016/j.jacc.2010.10.024 false true Reference 65851011 /api/reference/65851011 44. Mesquita T, Lin Y, Ibrahim A. Chronic low-grade inflammation in heart failure with preserved ejection fraction. Aging Cell. 2021;20(9):e13453. https://doi.org/10.1111/acel.13453., DOI: 10.1111/acel.13453 44 10.1111/acel.13453 false true Reference 65851012 /api/reference/65851012 45. Abel ED. Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021;321(1):E130–45. https://doi.org/10.1152/ajpendo.00158.2021., DOI: 10.1152/ajpendo.00158.2021 45 10.1152/ajpendo.00158.2021 false true Reference 65851013 /api/reference/65851013 46. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15–25. https://doi.org/10.1016/j.cmet.2004.12.003., DOI: 10.1016/j.cmet.2004.12.003 46 10.1016/j.cmet.2004.12.003 false true Reference 65851014 /api/reference/65851014 47. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8(10):774–85. https://doi.org/10.1038/nrm2249., DOI: 10.1038/nrm2249 47 10.1038/nrm2249 false true Reference 65851015 /api/reference/65851015 48. Suhara T, Baba Y, Shimada BK, Higa JK, Matsui T. The mTOR signaling pathway in myocardial dysfunction in type 2 diabetes mellitus. Curr Diabets Rep. 2017;17(6):38. https://doi.org/10.1007/s11892-017-0865-4., DOI: 10.1007/s11892-017-0865-4 48 10.1007/s11892-017-0865-4 false true Reference 65851016 /api/reference/65851016 49. Cohen P. The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol. 2006;7(11):867–73. https://doi.org/10.1038/nrm2043., DOI: 10.1038/nrm2043 49 10.1038/nrm2043 false true Reference 65851017 /api/reference/65851017 50. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol. 2008;153(S1):S137–53. https://doi.org/10.1038/sj.bjp.0707659., DOI: 10.1038/sj.bjp.0707659 50 10.1038/sj.bjp.0707659 false true Reference 65851018 /api/reference/65851018 51. Frati G, et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res. 2017;113(4):378–88. https://doi.org/10.1093/cvr/cvx011., DOI: 10.1093/cvr/cvx011 51 10.1093/cvr/cvx011 false true Reference 65851019 /api/reference/65851019 52. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol. 2011;12(8):695–708. https://doi.org/10.1038/ni.2065., DOI: 10.1038/ni.2065 52 10.1038/ni.2065 false true Reference 65851020 /api/reference/65851020 53. Mariappan N, et al. NF-κB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2010;85(3):473–83. https://doi.org/10.1093/cvr/cvp305., DOI: 10.1093/cvr/cvp305 53 10.1093/cvr/cvp305 false true Reference 65851021 /api/reference/65851021 54. Romeo G, Liu W-H, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51(7):2241–8. https://doi.org/10.2337/diabetes.51.7.2241., DOI: 10.2337/diabetes.51.7.2241 54 10.2337/diabetes.51.7.2241 false true Reference 65851022 /api/reference/65851022 55. Pan Y, et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes. 2014;63(10):3497–511. https://doi.org/10.2337/db13-1577., DOI: 10.2337/db13-1577 55 10.2337/db13-1577 false true Reference 65851023 /api/reference/65851023 56. Wong SL, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21(7):815–9. https://doi.org/10.1038/nm.3887., DOI: 10.1038/nm.3887 56 10.1038/nm.3887 false true Reference 65851024 /api/reference/65851024 57. Guo CA, Guo S. Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure. J Endocrinol. 2017;233(3):R131–43. https://doi.org/10.1530/JOE-16-0679., DOI: 10.1530/JOE-16-0679 57 10.1530/JOE-16-0679 false true Reference 65851025 /api/reference/65851025 58. Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834–44. https://doi.org/10.1056/NEJMoa1607141., DOI: 10.1056/NEJMoa1607141 58 10.1056/NEJMoa1607141 false true Reference 65851026 /api/reference/65851026 59. Ni R, et al. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radic Biol Med. 2016;90:12–23. https://doi.org/10.1016/j.freeradbiomed.2015.11.013., DOI: 10.1016/j.freeradbiomed.2015.11.013 59 10.1016/j.freeradbiomed.2015.11.013 false true Reference 65851027 /api/reference/65851027 60. Qi D, Young LH. AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab. 2015;26(8):422–9. https://doi.org/10.1016/j.tem.2015.05.010., DOI: 10.1016/j.tem.2015.05.010 60 10.1016/j.tem.2015.05.010 false true Reference 65851028 /api/reference/65851028 61. Calvert JW, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS–mediated signaling. Diabetes. 2008;57(3):696–705. https://doi.org/10.2337/db07-1098., DOI: 10.2337/db07-1098 61 10.2337/db07-1098 false true Reference 65851029 /api/reference/65851029 62. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–93. https://doi.org/10.1016/j.cell.2012.03.017., DOI: 10.1016/j.cell.2012.03.017 62 10.1016/j.cell.2012.03.017 false true Reference 65851030 /api/reference/65851030 63. Kim YC, Guan K-L. mTOR: a pharmacologic target for autophagy regulation. J Clin Investig. 2015;125(1):25–32. https://doi.org/10.1172/JCI73939., DOI: 10.1172/JCI73939 63 10.1172/JCI73939 false true Reference 65851031 /api/reference/65851031 64. VanderHaar E, Lee S, Bandhakavi S, Griffin TJ, Kim D-H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol. 2007;9(3):316–23. https://doi.org/10.1038/ncb1547., DOI: 10.1038/ncb1547 64 10.1038/ncb1547 false true Reference 65851032 /api/reference/65851032 65. Wang X, Su H, Ranek MJ. Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol. 2008;45(1):11–27. https://doi.org/10.1016/j.yjmcc.2008.03.025., DOI: 10.1016/j.yjmcc.2008.03.025 65 10.1016/j.yjmcc.2008.03.025 false true Reference 65851033 /api/reference/65851033 66. Williamson CL, Dabkowski ER, Dillmann WH, Hollander JM. Mitochondria protection from hypoxia/reoxygenation injury with mitochondria heat shock protein 70 overexpression. Am J Physiol Heart Circ Physiol. 2008;294(1):H249–56. https://doi.org/10.1152/ajpheart.00775.2007., DOI: 10.1152/ajpheart.00775.2007 66 10.1152/ajpheart.00775.2007 false true Reference 65851034 /api/reference/65851034 67. Shepherd DL, et al. Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the mitochondrial heat shock protein 70 (mtHsp70) nuclear locus. J Mol Cell Cardiol. 2018;119:104–15. https://doi.org/10.1016/j.yjmcc.2018.04.016., DOI: 10.1016/j.yjmcc.2018.04.016 67 10.1016/j.yjmcc.2018.04.016 false true /api/publication/36144886 Delalat Simin et al. Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets. (2025) CARDIOVASCULAR DIABETOLOGY 1475-2840 1475-2840 24 1<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> Delalat Simin ;    Sultana Innas* ;    Osman Hersh* ;    Sieme Marcel* ;    Zhazykbayeva Saltanat ;    Herwig Melissa ;    Budde Heidi ;    <a href="/gui2/?type=authors&mode=browse&sel=10055258" target="_blank">Kovács Árpád (Kovács Árpád Kardiológia) </a> UD/Faculty of Medicine/KardI/Klinikai Fiziológiai Tanszék ;    Kaçmaz Mustafa ;    Göztepe Eda ;    Borgmann Natalie ;    Shahriari Gelareh ;    Sasko Benjamin ;    Wintrich Jan ;    Haldenwang Peter ;    Schmidt Wolfgang E. ;    Fenske Wiebke ;    Khan Muchtiar ;    Jaquet Kornelia ;    Mügge Andreas ;    <a href="/gui2/?type=authors&mode=browse&sel=10054788" target="_blank">Máthé Domokos (Máthé Domokos Molekuláris képalkotás) </a> SU/FM/I/Departmnet of Biophysics and Radiation Biology; SU/FM/I/DBRB/ACF-SU In Vivo Imaging ;    <a href="/gui2/?type=authors&mode=browse&sel=10040905" target="_blank">Tóth Viktória E. (Tóth Viktória Farmakológia) </a> SU/FM/I/DPP/HCEMM-SU Cardiometabolic Immunology Research Group; SU/KSZE/Centre for Pharmacology and Pharmaceutical Research Development; SU/FM/I/Department of Pharmacology and Pharmacotherapy ;    <a href="/gui2/?type=authors&mode=browse&sel=10028393" target="_blank">Varga Zoltán V. (Varga Zoltán kardiovaszkuláris kutatás) </a> SU/FM/I/DPP/HCEMM-SU Cardiometabolic Immunology Research Group; SU/KSZE/Centre for Pharmacology and Pharmaceutical Research Development; SU/FM/I/Department of Pharmacology and Pharmacotherapy ;    <a href="/gui2/?type=authors&mode=browse&sel=10010125" target="_blank">Ferdinandy Péter (Ferdinandy Péter Farmakológia, molekuláris medicina) </a> SU/FM/I/DPP/HCEMM-SU Cardiometabolic Immunology Research Group; SU/KSZE/Centre for Pharmacology and Pharmaceutical Research Development; SU/FM/I/Department of Pharmacology and Pharmacotherapy ;    El-Battrawy Ibrahim ;    van Heerebeek Loek** ;    <a href="/gui2/?type=authors&mode=browse&sel=10086357" target="_blank">Hamdani Nazha ✉ (Hamdani Nazha Medicine) </a> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36144886" target="_blank">Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets</a></div> <div> CARDIOVASCULAR DIABETOLOGY (<a target="_blank" href="https://portal.issn.org/resource/ISSN/1475-2840">1475-2840</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1475-2840">1475-2840</a>): 24 1 Paper 211. 19 p. (2025) </div> <div class="pub-footer"> Language: English | <a style="color:blue" title="10.1186/s12933-025-02734-4" target="_blank" href="https://doi.org/10.1186/s12933-025-02734-4"> DOI </a> <a style="color:blue" title="001488651800006" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001488651800006"> WoS </a> <a style="color:blue" title="105005094697" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105005094697"> Scopus </a> <a style="color:blue" title="40369521" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40369521&dopt=Abstract"> PubMed </a> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Cardiology and Cardiovascular Medicine   Rank: D1</div> <div class="journal-subject">Journal subject: Scopus - Endocrinology, Diabetes and Metabolism   Rank: D1</div> <div class="journal-subject">Journal subject: Scopus - Internal Medicine   Rank: D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> Citing papers: 25 | Independent citation: 23 | Self citation: 2 | Unknown citation: 0 | Number of citations in WoS: 25 | Number of citations in Scopus: 15 | WoS/Scopus assigned: 25 | Number of citations with DOI: 25 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36144886&sort=publishedYear,desc&sort=title"> Number of cited publications: 7 </a> </div> <div class="mtid">Publication: 36144886 | Validated Core Citing | Journal Article ( Article ) | Scientific | kézi felvitel </div> <div class="funder"> (RRF-2.3.1-21-2022-00003), National Research, Development and Innovation Office (NKFIH) of Hungary(FK134751), (TKP2021-EGA-23) Funder: Ministry for Innovation and Technology </div> <div class="lastModified">Last Modified: 2025.12.27. 08:28 Admin Szuper (admin) </div> </div></div>